Project overview
Idiopathic pulmonary fibrosis (IPF) is a life-threatening condition of the lungs where tissue becomes thickened, stiff, and scarred, limiting the amount of oxygen getting into the blood. The aim of this project is to provide effective targeted therapies for sufferers to reduce symptoms of this devastating disease and improve their quality of life as well as to identify biomarkers for IPF patients.
Staff
Lead researcher
Collaborating research institutes, centres and groups
Research outputs
Xiaofan Liu,
Hong Zhou,
Yilu Zhou,
Xiaojun Wu,
Yang Zhao,
Yang Lu,
Weijun Tan,
Mingli Yuan,
Xuhong Ding,
Jinjing Zou,
Ruiyun Li,
Hailing Liu,
Yi Hu,
Hanxiang Nie,
, 2020
, Journal of Infection
, 81 (1) , e95--e97
Type: letterEditorial
Ayse Ertay,
Huiquan Liu,
Dian Liu,
Ping Peng,
Charlotte Hill,
Hua Xiong,
David Hancock,
Xianglin Yuan,
Mark Coldwell,
Michael Howell,
Julian Downward,
, 2020
, Cell Death and Disease
Type: article
Yuan Yuan,
Yilu Zhou,
Yali Li,
Charlotte Hill,
Zhenglin Jiang,
, 2020
, International Journal of Molecular Sciences
, 21 (4) , 1--19
DOI: 10.3390/ijms21041371
Type: article
Pagination
-
- 1
- 2
- 3
- 4